Related Experiment Video

Updated: May 23, 2026

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

The mechanism of carvedilol in experimental viral myocarditis

Li Yue-Chun1, Ge Li-Sha, Guan Xue-Qiang

  • 1Department of Cardiology, Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, China. liyuechun1980@sina.com.cn

Current Pharmaceutical Design
|March 27, 2012
PubMed

Insights

Carvedilol, a nonselective beta-blocker, shows significant protection against viral myocarditis in animal models. Its benefits, unlike metoprolol, stem from anti-inflammatory, antioxidant, and hemodynamic effects.

Area of Science:

  • Cardiology
  • Pharmacology
  • Immunology

Background:

  • Carvedilol is a nonselective beta-blocker with alpha-1 blocking and antioxidant properties.
  • Preclinical and clinical studies show carvedilol benefits in heart failure.
  • Limited research exists on carvedilol's efficacy in viral myocarditis animal models.

Purpose of the Study:

  • To review the use of carvedilol in animal models of viral myocarditis.
  • To compare carvedilol's effects with metoprolol in viral myocarditis.
  • To elucidate the mechanisms behind carvedilol's cardioprotective effects.

Main Methods:

  • Review of preclinical experiments and clinical trials on carvedilol in viral myocarditis models.
  • Comparative analysis of carvedilol versus metoprolol.
  • Investigation of cytokine production, oxidative stress, matrix metalloproteinases, and hemodynamic parameters.

Main Results:

  • Carvedilol demonstrated significant protection against viral myocarditis in animal models.
  • Metoprolol, a selective beta-1 blocker, did not show similar protective effects.
  • Carvedilol's superiority is linked to upregulated anti-inflammatory cytokines, downregulated pro-inflammatory cytokines, antioxidant activity, suppressed matrix metalloproteinases, and improved hemodynamics.

Conclusions:

  • Carvedilol offers significant cardioprotection in viral myocarditis animal models.
  • Carvedilol's multifaceted mechanism, including anti-inflammatory and antioxidant actions, underlies its efficacy.
  • Carvedilol presents a promising therapeutic option for viral myocarditis, outperforming metoprolol.

More Related Videos

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

Gene Transfer for Ischemic Heart Failure in a Preclinical Model07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...